Summary of Study ST000475
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000362. The data can be accessed directly via it's Project DOI: 10.21228/M8831S This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST000475 |
| Study Title | Metabolomic testing of a putative MDH inhibitor (global) |
| Study Type | drug treatment (single dose and timepoint) |
| Study Summary | HL-60 cells will be treated for 15hr with a putative MDH inhibitor or vehicle (n=5 per group) |
| Institute | University of Florida |
| Department | SECIM |
| Laboratory | Case Western University |
| Last Name | Wald |
| First Name | David |
| Address | 2103 Cornell Rd WRB3-530 Cleveland, OH 44106 |
| dnw@case.edu | |
| Phone | 2163685668 |
| Submit Date | 2016-09-12 |
| Num Groups | 2 |
| Total Subjects | 20 |
| Study Comments | Total subjects: 10 for global testing and 10 for targeted testing |
| Analysis Type Detail | LC-MS |
| Release Date | 2017-10-03 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Combined analysis:
| Analysis ID | AN000739 | AN000740 |
|---|---|---|
| Chromatography ID | CH000532 | CH000532 |
| MS ID | MS000656 | MS000657 |
| Analysis type | MS | MS |
| Chromatography type | Reversed phase | Reversed phase |
| Chromatography system | Thermo Scientific-Dionex Ultimate 3000 | Thermo Scientific-Dionex Ultimate 3000 |
| Column | ACE Excel 2 C18-PFP (100 x 2.1mm, 2um) | ACE Excel 2 C18-PFP (100 x 2.1mm, 2um) |
| MS Type | ESI | ESI |
| MS instrument type | Orbitrap | Orbitrap |
| MS instrument name | Thermo Q Exactive Orbitrap | Thermo Q Exactive Orbitrap |
| Ion Mode | POSITIVE | NEGATIVE |
| Units | peak area | Peak area |